Paxman AB (publ) (STO:PAX)
53.00
+2.00 (3.92%)
Mar 2, 2026, 5:24 PM CET
Paxman AB Revenue
Paxman AB had revenue of 89.41M SEK in the quarter ending September 30, 2025, with 31.17% growth. This brings the company's revenue in the last twelve months to 305.02M, up 20.69% year-over-year. In the year 2024, Paxman AB had annual revenue of 263.20M with 19.30% growth.
Revenue (ttm)
305.02M
Revenue Growth
+20.69%
P/S Ratio
3.81
Revenue / Employee
2.28M
Employees
142
Market Cap
1.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 263.20M | 42.59M | 19.30% |
| Dec 31, 2023 | 220.61M | 63.86M | 40.74% |
| Dec 31, 2022 | 156.75M | 52.04M | 49.70% |
| Dec 31, 2021 | 104.71M | 21.57M | 25.95% |
| Dec 31, 2020 | 83.14M | -12.53M | -13.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BICO Group AB | 1.50B |
| CellaVision AB | 748.45M |
| C-Rad AB | 441.90M |
| Mentice AB | 284.59M |
| Bactiguard Holding AB | 225.57M |
| Sedana Medical AB | 200.23M |
| OssDsign AB | 180.16M |
| Senzime AB | 104.02M |